AssayIndex
Reports by quarter

Reports submitted in 2026-Q2

Buyer-sourced sensitivity analysis added to every supplier scorecard. Median purity for the quarter is 98.90 % area, n=1009. Read the 2026-Q2 state-of-the-index report →

1,009 records26 pagesmedian on this page 99.13 %updated 30 Jul 2026
0479414192.093.094.095.096.097.098.099.0100.092.00–92.25 %: n=092.25–92.50 %: n=092.50–92.75 %: n=092.75–93.00 %: n=093.00–93.25 %: n=093.25–93.50 %: n=093.50–93.75 %: n=093.75–94.00 %: n=094.00–94.25 %: n=094.25–94.50 %: n=094.50–94.75 %: n=094.75–95.00 %: n=095.00–95.25 %: n=095.25–95.50 %: n=095.50–95.75 %: n=095.75–96.00 %: n=096.00–96.25 %: n=196.25–96.50 %: n=096.50–96.75 %: n=096.75–97.00 %: n=397.00–97.25 %: n=1397.25–97.50 %: n=2497.50–97.75 %: n=4597.75–98.00 %: n=4498.00–98.25 %: n=8298.25–98.50 %: n=11098.50–98.75 %: n=11198.75–99.00 %: n=11499.00–99.25 %: n=11299.25–99.50 %: n=10499.50–99.75 %: n=8099.75–100.00 %: n=166median 98.90 Purity (% area) Reports
Figure. Purity distribution for reports submitted in 2026-Q2. n=1009, median 98.90 % area. Same fixed 92–100 % domain as every other purity histogram on this site, so quarters can be compared by eye.
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2026-043010TirzepatideKPKP-2602-X5446VendorInvestigate2026-Q298.586.3891.5Buyer-sourced1MARGINAL
AX-2026-041609PinealonQSCQSC-2602-V8219VendorInvestigate2026-Q299.837.58—Buyer-sourced0FAIL
AX-2026-042344BPC-157HJHJ-2511-U3414Janoshik2026-Q299.184.92—Supplier-supplied2MARGINAL
AX-2026-042746N-Acetyl Semax AmideGGPepsGGPE-2512-A1206PeptideMeter2026-Q298.976.67—Supplier-supplied2MARGINAL
AX-2026-043023SemaglutideKPKP-2511-J4998Janoshik2026-Q299.538.11—Supplier-supplied1FAIL
AX-2026-042914GonadorelinMKMMKM-2604-A2596Janoshik2026-Q299.935.19—Supplier-supplied0PASS
AX-2026-041952MOTS-cTFCTFC-2605-R4770PeptideMeter2026-Q299.655.6095.5Supplier-supplied0PASS
AX-2026-041664SemaglutideQSCQSC-2511-M9226Nordanalyt2026-Q299.704.3196.0Supplier-supplied1MARGINAL
AX-2026-041208NAD+WWBWWB-2601-V1583VendorInvestigate2026-Q299.1811.38100.9Buyer-sourced0FAIL
AX-2026-042884BPC-157MKMMKM-2605-X2575Nordanalyt2026-Q298.122.89—Laboratory-retained1MARGINAL
AX-2026-042234N-Acetyl Semax AmideHomopeptideHOMO-2603-C1382Janoshik2026-Q298.998.0099.6Supplier-supplied0PASS
AX-2026-041947SemaxTFCTFC-2602-F4591Nordanalyt2026-Q299.298.9892.3Supplier-supplied0PASS
AX-2026-041864PT-141 (Bremelanotide)JEEPJEEP-2601-K3015Janoshik2026-Q299.353.9992.2Supplier-supplied0PASS
AX-2026-041712ExenatideQSCQSC-2602-P9435Medutest2026-Q299.484.78—Supplier-supplied0PASS
AX-2026-042946TirzepatideMKMMKM-2601-L3752Medutest2026-Q297.718.10—Supplier-supplied1FAIL
AX-2026-042857RetatrutideGGPepsGGPE-2601-C2423Kestrel2026-Q297.514.23106.4Supplier-supplied1MARGINAL
AX-2026-042822TB-500GGPepsGGPE-2605-J2051PeptideMeter2026-Q299.344.28—Supplier-supplied1MARGINAL
AX-2026-042321TirzepatideHJHJ-2605-D3120VendorInvestigate2026-Q298.114.22—Buyer-sourced2MARGINAL
AX-2026-041262SemaglutideWWBWWB-2604-J2590Medutest2026-Q299.066.7995.6Supplier-supplied1MARGINAL
AX-2026-042618KPVGGPepsGGPE-2511-K8830Janoshik2026-Q298.625.19103.1Supplier-supplied1FAIL
AX-2026-042468SemaglutideSWBSWB-2603-T5632Janoshik2026-Q299.176.4989.8Supplier-supplied3MARGINAL
AX-2026-041698SemaglutideQSCQSC-2604-H9231PeptideMeter2026-Q299.326.09—Supplier-supplied1MARGINAL
AX-2026-043516MGFBCHBCH-2511-D7240PeptideMeter2026-Q299.035.80—Supplier-supplied0PASS
AX-2026-042953SemaglutideKPKP-2601-K4658VendorInvestigate2026-Q298.035.8991.0Buyer-sourced1MARGINAL
AX-2026-042560MazdutideERPERP-2603-D7882VendorInvestigate2026-Q297.283.81104.1Buyer-sourced2MARGINAL
AX-2026-041940SemaxTFCTFC-2602-F4591Janoshik2026-Q299.068.3898.8Buyer-sourced0PASS
AX-2026-041518RetatrutideQYBQYB-2602-R6263Janoshik2026-Q297.875.72101.7Supplier-supplied1MARGINAL
AX-2026-043144GHK-CuSSASSA-2604-V7620Janoshik2026-Q298.355.25105.8Supplier-supplied0PASS
AX-2026-043141SemaxSSASSA-2604-L7628Kestrel2026-Q298.848.5893.2Supplier-supplied2MARGINAL
AX-2026-042026IpamorelinTFCTFC-2603-M6766Janoshik2026-Q299.934.8591.9Supplier-supplied0PASS
AX-2026-041464SS-31 (Elamipretide)QYBQYB-2512-H5402Janoshik2026-Q299.514.72—Supplier-supplied1MARGINAL
AX-2026-041309IpamorelinWWBWWB-2604-E3153Janoshik2026-Q299.936.14—Supplier-supplied0PASS
AX-2026-042911GonadorelinMKMMKM-2604-A2596Medutest2026-Q299.085.55—Buyer-sourced1MARGINAL
AX-2026-042639IGF-1 LR3GGPepsGGPE-2604-K8140Janoshik2026-Q298.112.5788.0Supplier-supplied1MARGINAL
AX-2026-042361SermorelinHJHJ-2605-A4196Medutest2026-Q298.935.4389.8Supplier-supplied1MARGINAL
AX-2026-041590SS-31 (Elamipretide)QSCQSC-2605-E6873Janoshik2026-Q299.262.5892.4Supplier-supplied0PASS
AX-2026-041284SemaglutideWWBWWB-2603-N3120Medutest2026-Q299.556.01—Supplier-supplied2MARGINAL
AX-2026-041261SemaglutideWWBWWB-2604-J2590Janoshik2026-Q299.937.0599.3Supplier-supplied0PASS
AX-2026-041219ThymulinWWBWWB-2602-S2129PeptideMeter2026-Q299.043.7989.7Supplier-supplied2MARGINAL
AX-2026-043007TirzepatideKPKP-2602-X5446Kestrel2026-Q299.257.01—Supplier-supplied1MARGINAL